Calliditas Therapeutics AB (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
19.45
0.99 (5.36%)
At close: May 20, 2022 4:00 PM
18.70
-0.75 (-3.86%)
After-hours:May 20, 2022 5:05 PM EDT
Income Statement (Quarterly)
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
| Quarter Ended | 2021-12-31 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0.4 | 0 | 0 | 0.47 | 46.59 | 0 | 138.24 |
| Revenue Growth (YoY) | - | - | - | -99.14% | - | - | - | - | - | - |
| Gross Profit | - | 0 | 0 | 0.4 | 0 | 0 | 0.47 | 46.59 | 0 | 138.24 |
| Selling, General & Admin | - | 84.37 | 58.78 | 63.88 | 41.04 | 18.8 | 18.01 | 23.79 | 10.3 | 19 |
| Research & Development | - | 75.02 | 90.08 | 73.99 | 64.89 | 48.39 | 54.11 | 41.71 | 46.19 | 31.19 |
| Other Operating Expenses | 0 | 0.01 | 1.93 | -1.53 | -1.03 | -0.62 | 0.69 | -0.87 | -3.84 | 2.67 |
| Operating Expenses | - | 159.4 | 150.78 | 136.34 | 104.89 | 66.56 | 72.8 | 64.63 | 52.64 | 52.86 |
| Operating Income | - | -159.4 | -150.78 | -135.94 | -104.89 | -66.56 | -72.33 | -18.04 | -52.64 | 85.39 |
| Interest Expense / Income | - | 5.81 | -14.61 | 37.88 | 33.05 | -5.3 | -8.65 | 5.86 | -2.5 | 2.22 |
| Other Expense / Income | 0 | -3.23 | -1.41 | -3.56 | 0 | 0 | 0 | -0.93 | 0 | 0 |
| Pretax Income | 0 | -161.98 | -134.76 | -170.26 | -137.94 | -61.26 | -63.68 | -22.97 | -50.14 | 83.17 |
| Income Tax | - | -2.14 | -9.31 | 0.18 | 0.08 | 0.07 | 0.04 | 0.08 | 0 | 0 |
| Net Income | - | -159.84 | -125.46 | -170.43 | -138.02 | -61.33 | -63.72 | -23.05 | -50.14 | 83.17 |
| Net Income Common | - | -159.84 | -125.46 | -170.43 | -138.02 | -61.33 | -63.72 | -23.05 | -50.14 | 83.17 |
| Shares Outstanding (Basic) | 50 | 50 | 50 | 46 | 46 | 46 | 46 | 46 | - | - |
| EPS (Basic) | - | -6.40 | -5.02 | -7.48 | -5.54 | -3.00 | -3.30 | -1.46 | -2.60 | 4.72 |
| EPS (Diluted) | - | -6.40 | -5.02 | -7.48 | -5.54 | -3.00 | -3.30 | -1.46 | -2.60 | 4.70 |
| Free Cash Flow Per Share | - | -5.32 | -5.37 | -5.19 | -4.46 | -2.90 | -0.81 | -1.97 | - | - |
| Gross Margin | - | - | - | 100.00% | - | - | 100.00% | 100.00% | - | 100.00% |
| Operating Margin | - | - | - | -33985.25% | - | - | -15258.65% | -38.73% | - | 61.77% |
| Profit Margin | - | - | - | -42607.75% | - | - | -13441.98% | -49.48% | - | 60.16% |
| Free Cash Flow Margin | - | - | - | -30018.50% | - | - | -3960.97% | -97.78% | - | -42.90% |
| Effective Tax Rate | - | 1.32% | 6.90% | -0.10% | -0.06% | -0.11% | -0.06% | -0.34% | 0.00% | 0.00% |
| EBITDA | - | -156.17 | -149.37 | -132.38 | -104.89 | -66.56 | -72.33 | -17.12 | -52.64 | 85.39 |
| EBITDA Margin | - | - | - | -33094.25% | - | - | -15258.65% | -36.74% | - | 61.77% |
| EBIT | - | -156.17 | -149.37 | -132.38 | -104.89 | -66.56 | -72.33 | -17.12 | -52.64 | 85.39 |
| EBIT Margin | - | - | - | -33094.25% | - | - | -15258.65% | -36.74% | - | 61.77% |
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).